Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients
Clinical trial NCT01632358 · COMPLETED
Trial details
- NCT number
- NCT01632358
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2012-12-01
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.